English
中文
русск
français
español
العربية
It takes around min to read this article.
China's CanSino Biologics Inc said on Wednesday its COVID-19 vaccine was approved in Mexico for emergency use for people of 18 years of age or older.
On Monday, Pakistan said CanSinoBio's vaccine showed 65.7 percent efficacy in preventing symptomatic cases and a 90.98 percent success rate in stopping severe disease in an interim analysis of global trials.
Original Text (This is the original text for your reference.)
China's CanSino Biologics Inc said on Wednesday its COVID-19 vaccine was approved in Mexico for emergency use for people of 18 years of age or older.
On Monday, Pakistan said CanSinoBio's vaccine showed 65.7 percent efficacy in preventing symptomatic cases and a 90.98 percent success rate in stopping severe disease in an interim analysis of global trials.
Select your report category*
Reason*
Your level privilege is in sufficient. You can go to the “User Center” to view your level information and perform points tasks to upgrade your level.
New sign-in location：
Last sign-in location：
Last sign-in date：
About to jump to an external site.
Security unknown, whether to continue
User Center
My Training Class
Feedback
Report
Share
Comments
Something to say?
Log in or Sign up for free